Coluracetam Pure Raw Nootropic Powder CAS 135463-81-9

Coluracetam Pure Raw Nootropic Powder CAS 135463-81-9

1. Coluracetam 135463-81-9
2. Product Name: Coluracetam MKC-231
3. Chemical Name: N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-
4. 1-yl)acetamide
5. CAS No.: 135463-81-9
6. Formula: C19H23N3O3
7. Purity:99%
8. Molecular Weight:341.40
9. Appearance:white crystal powder
10. Boiling Point:634.1C at 760 mmHg C
11. Description: Coluracetam (BCI-540) is a nootropic drug of the racetam family. (for research only
12. Application:mainly applied to promote intellectual product. /raw material used in Synthesis/
13. pharmaceutical raw material

Coluracetam Description:

1. Coluracetam is a nootropic drug of the racetam family. Coluracetam was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer’s disease.

2. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a “Qualifying Therapeutic Discovery Program Grant” by the state of California.

3. Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently out-licensing the drug for this purpose. It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.

Coluracetam Function:

• Enhance mental intelligence
• Boost memory and leaning capabilities
• Improve brain power to solve problems and protect it from any chemical or physical injury
• Enhance motivation level
• Enhance the control of cortical/subcortical brain mechanism
• Improve sensory perception​

Coluracetam Application:

1. Coluracetam enhances high-affinity choline uptake (HACU) which is the rate-limiting step of acetylcholine (ACh) synthesis, and is the only known choline uptake enhancer to currently exist.

2. Studies have shown Coluracetam to improve learning impairment on a single oral dose given to rats which have been exposed to cholinergic neurotoxins. Subsequent studies have shown that it may induce long-lasting procognitive effects by changing the choline transporter regulation system.